提供医疗用品包以改善莫桑比克产前保健质量:一项阶梯楔形整群随机试验
在莫桑比克十家产前保健诊所开展阶梯楔形整群随机试验,评估基于医疗用品包的供应链策略对产前保健质量的影响。干预后贫血筛查比例从14.6%升至97.7%,蛋白尿筛查从9.9%升至97.1%,甲苯咪唑给药从51.4%升至88.2%,差异均显著。
要点
- 干预后首次产前检查贫血筛查比例从14.6%升至97.7%(调整OR 832.40)。
- 蛋白尿筛查比例从9.9%升至97.1%(调整OR 1875.18)。
- 甲苯咪唑给药比例从51.4%升至88.2%(调整OR 1.88)。
核心结论
- 解决服务点缺货的供应链策略可大幅改善产前保健质量。
研究设计与样本
- 在莫桑比克十家产前保健诊所开展的务实阶梯楔形整群随机对照试验,纳入所有就诊孕妇。
- 干预包括医疗用品包、储存柜、库存追踪表和一天培训,按意向性治疗原则分析。
主要发现
- 首次产前检查贫血筛查比例从对照组14.6%(5519/37826)升至干预组97.7%(30057/30772),调整OR 832.40(99% CI 666.81-1039.11),p<0.0001。
- 蛋白尿筛查比例从对照组9.9%(3739/37826)升至干预组97.1%(29874/30772),调整OR 1875.18(99% CI 1447.56-2429.11),p<0.0001。
- 甲苯咪唑给药比例从对照组51.4%(17926/34842)升至干预组88.2%(24960/28294),调整OR 1.88(99% CI 1.70-2.09),p<0.0001。
- 效应立即可见并持续,各中心间异质性可忽略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High levels of maternal and newborn mortality and morbidity remain a daunting reality in many low-income countries. Several interventions delivered during antenatal care have been shown to improve maternal and newborn outcomes, but stockouts of medical supplies at point of care can prevent implementation of these services. We aimed to evaluate whether a supply chain strategy based on the provision of kits could improve quality of care. METHODS: We did a pragmatic, stepped-wedge, cluster-randomised controlled trial at ten antenatal care clinics in Mozambique. Clinics were eligible if they were not already implementing the proposed antenatal care package; they served at least 200 new pregnant women per year; they had Maternal and Child Health (MCH) nurses; and they were willing to participate. All women attending antenatal care visits at the participating clinics were included in the trial. Participating clinics were randomly assigned to shift from control to intervention on prespecified start dates. The intervention involved four components (kits with medical supplies, a cupboard to store these supplies, a tracking sheet to monitor stocks, and a one-day training session). The primary outcomes were the proportion of women screened for anaemia and proteinuria, and the proportion of women who received mebendazole in the first antenatal care visit. The intervention was delivered under routine care conditions, and analyses were done according to the intention-to-treat principle. This trial is registered with the Pan African Clinical Trial Registry, number PACTR201306000550192. FINDINGS: Between March, 2014, and January, 2016, 218 277 antenatal care visits were registered, with 68 598 first and 149 679 follow-up visits. We found significant improvements in all three primary outcomes. In first visits, 5519 (14·6%) of 37 826 women were screened for anaemia in the control period, compared with 30 057 (97·7%) of 30 772 in the intervention period (adjusted odds ratio 832·40; 99% CI 666·81-1039·11; p<0·0001); 3739 (9·9%) of 37 826 women were screened for proteinuria in the control period, compared with 29 874 (97·1%) of 30 772 in the intervention period (1875·18; 1447·56-2429·11; p<0·0001); and 17 926 (51·4%) of 34 842 received mebendazole in the control period, compared with 24 960 (88·2%) of 28 294 in the intervention period (1·88; 1·70-2·09; p<0·0001). The effect was immediate and sustained over time, with negligible heterogeneity between sites. INTERPRETATION: A supply chain strategy that resolves stockouts at point of care can result in a vast improvement in quality during antenatal care visits, when compared with the routine national process for procurement and distribution of supplies. FUNDING: Government of Flanders and the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction.
引用
- Betrán AP, Bergel E, Griffin S, et al. Provision of medical supply kits to improve quality of antenatal care in Mozambique: a stepped-wedge cluster randomised trial. Lancet Glob Health. 2018. PMID: 29241615. doi:10.1016/S2214-109X(17)30421-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。